News

CHICAGO -- A once-weekly basal insulin had similar safety and efficacy to a daily insulin option, a series of trials from the ...
One-year data suggest allogeneic stem cell-derived islet-cell therapy could become a future option for those with type 1 ...
CHICAGO -- An investigational allogeneic stem cell-derived islet-cell therapy helped almost all patients with type 1 diabetes ...
A revolutionary stem cell therapy has helped Amanda Smith ditch insulin injections for good, offering new hope to diabetics ...
One-year results from the company's FORWARD-101 trial of islet cell therapy zimislecel (also known as VX-880) showed that all ...
One of the first brain cells shown to make insulin is the neurogliaform cell. These live in a brain area important for ...
In previous treat-to-target trials, adjustments to the dose of basal insulin have been made at least weekly, according to ...
Inhaled insulin is an “important alternative” to injected rapid-acting analog insulin for children and teens with diabetes, ...
Amanda Smith has kicked insulin to the curb in what experts are calling a milestone in the fight against Type 1 diabetes.
Insulin resistance detected by routine triglyceride-glucose (TyG) index can flag people with early Alzheimer's who are four ...
A new study published in the Journal of Ultrasound in Medicine ultrasound of one's thigh or shoulder muscle can help detect ...
Good morning! Today, we get deeper into the ousting of Nicole Verdun at the FDA, see promise from Vertex’s cell therapy for ...